CMP Pharma Releases Liqrev, First FDA-Approved Liquid Suspension of Sildenafil
Medicine created for patients with difficulty swallowing tablets.
CMP Pharma, a pharmaceutical manufacturer, announced that Liqrev, the first FDA-approved ready-made oral liquid of sildenafil, is now available. Created for patients with the inability to swallow tablets, the medication is designated for the treatment of pulmonary arterial hypertension.
"Liqrev is for patients who need a liquid formulation because they have difficulty swallowing tablets. This product is a nice addition to our portfolio of liquids for patients with pulmonary arterial hypertension (PAH)," said Gerald Sakowski, CEO, CMP Pharma, Inc.
Reference: CMP Pharma, Inc Announces that Liqrev®, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available. PR Newswire. June 21, 2023. Accessed June 22, 2023. https://www.prnewswire.com/news-releases/cmp-pharma-inc-announces-that-liqrev-the-first-and-only-ready-made-fda-approved-liquid-suspension-of-sildenafil-is-now-available-301856229.html
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
